Literature DB >> 33141013

Syndrome of inappropriate antidiuretic hormone secretion induced by suvorexant: a case report.

Manabu Takano1, Tsuyoshi Okada1, Toshiyuki Kobayashi1, Shiro Suda1.   

Abstract

NONE: Syndrome of inappropriate antidiuretic hormone release (SIADH) can sometimes be caused by an adverse effect of certain psychotropic drugs. However, suvorexant has never been reported to cause SIADH. A 77-year-old man with type 2 diabetes was admitted to the Jichi Medical University Hospital for the treatment of major depression. During the treatment, he was prescribed suvorexant for insomnia. Twelve days after the initiation of suvorexant, he developed hyponatremia, which met the diagnostic criteria of SIADH. We suspected the hyponatremia to be an adverse drug effect of suvorexant because no other cause for SIADH was detected. Accordingly, suvorexant was discontinued 15 days after the onset of SIADH, and hyponatremia improved in 6 days. Although suvorexant has fewer adverse drug reactions and is considered relatively safe, clinicians should be aware of the possibility of SIADH induced by suvorexant.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  adverse drug reactions; suvorexant; syndrome of inappropriate antidiuretic hormone secretion

Mesh:

Substances:

Year:  2021        PMID: 33141013      PMCID: PMC7927339          DOI: 10.5664/jcsm.8970

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  8 in total

Review 1.  Antidepressants and the risk of hyponatremia: a class-by-class review of literature.

Authors:  Livia De Picker; Filip Van Den Eede; Glenn Dumont; Greta Moorkens; Bernard G C Sabbe
Journal:  Psychosomatics       Date:  2014-04-21       Impact factor: 2.386

2.  Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.

Authors:  Michael J Huber; Yuanyuan Fan; Enshe Jiang; Fengli Zhu; Robert A Larson; Jianqun Yan; Ningjun Li; Qing-Hui Chen; Zhiying Shan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-30       Impact factor: 4.733

Review 3.  The syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  F C Bartter; W B Schwartz
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

Review 4.  Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis.

Authors:  Akira Kuriyama; Hiromitsu Tabata
Journal:  Sleep Med Rev       Date:  2016-10-28       Impact factor: 11.609

5.  Zolpidem induced hyponatremia: a case report.

Authors:  Shanmuga Priya S; Britto Dl; Saravanan T
Journal:  J Clin Diagn Res       Date:  2014-09-20

6.  The suspect - SIADH.

Authors:  Kristen Tee; Jerry Dang
Journal:  Aust Fam Physician       Date:  2017-09

7.  The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies.

Authors:  Daniel Shepshelovich; Chiya Leibovitch; Alina Klein; Shirit Zoldan; Gai Milo; Tzippy Shochat; Benaya Rozen-zvi; Anat Gafter-Gvili; Meir Lahav
Journal:  Eur J Intern Med       Date:  2015-11-10       Impact factor: 4.487

8.  Clinical causality assessment for adverse drug reactions.

Authors:  Satyen Parida
Journal:  Indian J Anaesth       Date:  2013-05
  8 in total
  1 in total

Review 1.  Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).

Authors:  Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Joseph Keefe; Elasaf Gilbert; Jamal Hasoon; Michael E Thase; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.